Publicacions en què col·labora amb FRANCISCO COLINA RUIZ-DELGADO (24)

2013

  1. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation

    Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415

2009

  1. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C

    Liver Transplantation, Vol. 15, Núm. 8, pp. 948-955

2006

  1. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation

    Liver Transplantation, Vol. 12, Núm. 12, pp. 1805-1812

2001

  1. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989

    Hepato-Gastroenterology, Vol. 48, Núm. 41, pp. 1435-1442

1998

  1. Clinical, virological, and histologic evolution of hepatitis C virus infection in liver transplant recipients

    Clinical Infectious Diseases, Vol. 26, Núm. 1, pp. 48-55

  2. Invasive fungal infections in liver transplant recipients: Analysis of 21 cases

    Medicina Clinica, Vol. 110, Núm. 11, pp. 406-410

  3. Liver transplantation in HBsAg+ patients: Results according to patient selection and treatment strategies

    Transplantation Proceedings

  4. Steroid withdrawal is safe and beneficial in stable cyclosporine- treated liver transplant patients

    Journal of Hepatology, Vol. 28, Núm. 1, pp. 150-156

1997

  1. Presence of human herpesvirus 8 in Kaposi's sarcoma developing in a liver graft

    Transplantology: Journal of Cell and Organ Transplantation

1996

  1. Kaposi's sarcoma developing in a liver graft

    Transplantation, Vol. 61, Núm. 12, pp. 1779-1781

  2. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: Report of a case and literature review

    Hepato-Gastroenterology, Vol. 43, Núm. 10, pp. 1057-1061

1995

  1. High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients

    Transplantation Proceedings

  2. Histological diagnosis of cytomegalovirus hepatitis in liver allografts

    Journal of Clinical Pathology, Vol. 48, Núm. 4, pp. 351-357

  3. Liver transplantation in patients with cirrhosis of unknown cause (cryptogenic cirrhosis): Long-term follow-up

    Transplantation Proceedings

1994

  1. Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients - Role of serology and HCV RNA detection

    Digestive Diseases and Sciences, Vol. 39, Núm. 5, pp. 965-969

  2. Etiopathogenesis and prognosis of centrilobular necrosis in hepatic grafts

    Journal of Hepatology, Vol. 21, Núm. 3, pp. 441-446

  3. OKT3/antithymocyte globulin immunoprophylaxis in the prevention of recurrence of acute vanishing bile duct syndrome in retransplanted patients

    Transplantation Proceedings

1993

  1. Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies

    Antimicrobial Agents and Chemotherapy

  2. Liver transplantation in chronic viral B and C hepatitis

    Journal of Hepatology, Vol. 17, Núm. SUPPL. 3

  3. Neurologic complications in liver transplantation

    Acta Neurologica Scandinavica, Vol. 87, Núm. 1, pp. 25-31